mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.8 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.8 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.0092 |
0.8 |
mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
-0.0091 |
0.8 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0084 |
0.8 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
0.0092 |
0.8 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
-0.007 |
0.8 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.8 |
mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
0.0081 |
0.8 |